An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder

Wayne A. Hening, Richard P. Allen, Christopher J. Earley, Daniel L. Picchietti, Michael H. Silber

Research output: Contribution to journalReview article

Abstract

This paper reviews evidence from April, 1998 through April 2002 for the dopaminergic treatment of the restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). There has been increased study of dopaminergic agents for the treatment of these conditions since publication of a review paper and practice parameters that covered all types of medical treatment of RLS and PLMD in 1999. For this reason, the Restless Legs Syndrome Task Force and the Standards of Practice Committee decided to update the evidence on dopaminergic treatment of these conditions. This paper reviews the literature on levodopa, dopaminergic agonists (pergolide, pramipexole, ropinirole, talipexole, cabergoline, piribidel, DHEC), and other dopaminergic agents (amantadine, selegiline).

Original languageEnglish (US)
Pages (from-to)560-583
Number of pages24
JournalSleep
Volume27
Issue number3
DOIs
StatePublished - Jan 1 2004
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder'. Together they form a unique fingerprint.

  • Cite this